Our results demonstrated that VPS34-IN-1 effectively impeded EBOVΔVP30-EGFP infection in a dose-dependent manner (IC50 = 371nM) with negligible cellular toxicity (Fig 4A and 4B). Here, PIK3C3 is linked to infection.